Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $40.26 $52.54 Friday, 10th May 2024 RARE stock ended at $40.90. This is 0.776% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.23% from a day low at $40.26 to a day high of $41.56.
90 days $40.26 $54.55
52 weeks $31.52 $54.98

Historical Ultragenyx Pharmaceutical Inc. prices

Date Open High Low Close Volume
Mar 21, 2016 $55.79 $58.61 $55.43 $57.69 928 200
Mar 18, 2016 $54.63 $57.62 $51.02 $56.32 1 221 500
Mar 17, 2016 $53.44 $54.78 $50.22 $54.28 671 800
Mar 16, 2016 $54.22 $55.68 $52.10 $53.43 556 100
Mar 15, 2016 $57.77 $58.17 $53.59 $54.73 526 600
Mar 14, 2016 $59.93 $61.90 $58.03 $58.70 646 100
Mar 11, 2016 $56.01 $60.60 $55.00 $60.00 838 500
Mar 10, 2016 $59.09 $61.03 $53.25 $54.95 964 500
Mar 09, 2016 $62.35 $62.93 $58.00 $58.61 920 700
Mar 08, 2016 $66.50 $67.00 $61.52 $61.90 807 400
Mar 07, 2016 $62.24 $66.38 $60.53 $65.82 643 300
Mar 04, 2016 $64.17 $65.19 $62.00 $62.74 660 200
Mar 03, 2016 $67.70 $68.65 $62.60 $63.38 617 700
Mar 02, 2016 $64.00 $70.00 $63.53 $67.78 976 700
Mar 01, 2016 $61.63 $64.85 $59.46 $64.70 811 600
Feb 29, 2016 $62.56 $64.77 $60.04 $60.99 866 600
Feb 26, 2016 $60.52 $63.87 $59.11 $62.30 589 700
Feb 25, 2016 $62.70 $64.97 $60.03 $60.85 638 300
Feb 24, 2016 $60.02 $62.99 $58.24 $62.74 494 200
Feb 23, 2016 $62.74 $64.19 $60.65 $60.83 741 700
Feb 22, 2016 $64.11 $65.95 $62.39 $63.72 657 700
Feb 19, 2016 $60.47 $64.84 $59.09 $63.27 485 100
Feb 18, 2016 $61.86 $63.67 $59.06 $60.52 778 900
Feb 17, 2016 $59.08 $63.46 $57.50 $61.50 726 500
Feb 16, 2016 $55.80 $58.90 $55.09 $57.89 673 800
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT